IP Library Granted Patent US 9,574,220
Granted Patent B2
US 9,574,220 · App. 14/644,989 · Granted Feb 21, 2017

Enzyme assays on a droplet actuator

Inventors: Allen E Eckhardt (San Diego, CA); Carrie Graham (Raleigh, NC); Ramakrishna Sista (San Diego, CA); Vamsee K. Pamula (Cary, NC); Theodore Winger (Morrisville, NC); Tong Wang (Cary, NC); Yalin Xiong (Morrisville, NC); Ning Wu (Raleigh, NC); Sanjay Saha (Andhra Pradesh, IN); Gajendrasinh Raolji (Andhra Pradesh, IN); Raveendra Dayam (Andhra Pradesh, IN)
Assignee: Advanced Liquid Logic, Inc.
C12Q1/34C07D311/16C07D311/18C07D311/20C07D405/12C07D413/12C07H15/203C07H17/075C12Q1/25C12Q1/44C12Q1/54G01N21/6452G01N33/5438B01L3/502784B01L2300/0654B01L2300/0816B01L2300/18B01L2400/043B01L2400/0427G01N2333/916G01N2333/926G01N2800/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,574,220
App. No.
14/644,989
Granted
Feb 21, 2017
Kind
B2
Abstract

The invention is directed to droplet actuator devices and assay methods. The invention includes assay methods of conducting an assay comprising combining a sample with an umbelliferyl derivative, wherein the sample potentially comprises an enzyme capable of cleaving the umbelliferyl derivative and where the umbelliferyl derivative comprises an umbelliferyl core modified with one or more modifying moieties.

Claims (72)

1. A compound having one of the following general formulas:

wherein

X is, independently, selected from the group consisting of O, S, and NH,

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, and disaccharides;

R2 is H, a monosaccharide, a disaccharide, or a polyhydric alcohol;

R3 is a hydrophilic oligomer or polymer selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers; carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides; and

n is an integer of from 1 to 100.

2. The compound of claim 1 , wherein n is an integer of from 1 to 50.

3. The compound of claim 1 , wherein n is an integer of from 1 to 25.

4. The compound of claim 1 , wherein n is an integer of from 1 to 10.

5. The compound of claim 1 , wherein the hydrophilic polymer or oligomer comprises a polyethylene glycol moiety.

6. The compound of claim 5 , wherein the polyethylene glycol moiety of the oligomer has at least 2 polyethylene glycol subunits.

7. The compound of claim 5 , wherein the polyethylene glycol moiety of the oligomer has at least 5 polyethylene glycol subunits.

8. The compound of claim 5 , wherein the polyethylene glycol moiety has at least 7 polyethylene glycol subunits.

9. The compound of claim 1 , wherein the hydrophilic polymer or oligomer comprises polar or charged functional groups that render the polymer or oligomer soluble in water.

10. The compound of claim 9 , wherein the hydrophilic polymer or oligomer is selected from the group consisting of polyacrylic acid, polyacrylamide, polymaleic anhydride polymers, polyallylamine, polyethyleneimine, polyoxazoline, polylysine, and co-polymers thereof.

11. The compound of claim 9 , wherein the hydrophilic polymer or oligomer comprises one or more other moieties selected from the group consisting of additional hydrophilic moieties, lipophilic moieties, spacer moieties, linker moieties, and terminating moieties.

12. The compound of claim 11 , wherein the one or more additional hydrophilic moieties are selected from the group consisting of sugars, polyhydric alcohols, polyalkylene oxides, and polyamine/PEG copolymers.

13. The compound of claim 11 , wherein the spacer moieties are selected from the group consisting of sugar, cholesterol and glycerine moieties.

14. The compound of claim 11 , wherein the terminating moieties are present at the one or more ends of the oligomer not coupled to the 4-HU backbone, and are selected from the group consisting of C1-6 alkyl and alkoxy moieties.

15. The compound of claim 14 , wherein the terminating moiety is methyl or methoxy.

16. A compound of claim 1 , having one of the following formulas:

wherein:

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides;

R3 is a hydrophilic oligomer or polymer, which can be selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers, carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides;

X is, independently, selected from the group consisting of O, S, and NH; and

n is an integer of from 1 to 100.

17. The compound of claim 16 , wherein n is an integer of from 1 to 50.

18. The compound of claim 16 , wherein n is an integer of from 1 to 25.

19. The compound of claim 16 , wherein n is an integer of from 1 to 10.

20. The compound of claim 12 , wherein the sugar moieties are coupled to the 4-MU core structure at position R2, and are selected from the group consisting of:

21. The compound of claim 12 , wherein the polyhydric alcohols are selected from the group consisting of glycol (2-carbon), glycerol (3-carbon), erythritol (4-carbon), threitol (4-carbon), arabitol (5-carbon), xylitol (5-carbon), ribitol (5-carbon), mannitol (6-carbon), sorbitol (6-carbon), dulcitol (6-carbon), iditol (6-carbon), isomalt (12-carbon), maltitol (12-carbon), lactitol (12-carbon), and polyglycitol.

22. A compound selected from the group consisting of:

versions thereof in which one or more amines is quaternized to yield a quaternary ammonium salt,

and pharmaceutically acceptable salts thereof.

23. A method of conducting an assay, the method comprising combining with a compound having one of the following general formulas, a blood sample potentially comprising an enzyme capable of cleaving said compound:

wherein

X is, independently, selected from the group consisting of O, S, and NH,

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, and disaccharides;

R2 is H, a monosaccharide, a disaccharide, or a polyhydric alcohol;

R3 is a hydrophilic oligomer or polymer selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers; carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides; and

n is an integer of from 1 to 100.

24. A process for preparing compounds of Formula 2

comprising one of the following reactions:

wherein

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides;

R2 is H, a monosaccharide, a disaccharide, or a polyhydric alcohol;

R3 is a hydrophilic oligomer or polymer, which can be selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers, carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides;

halo is selected from the group consisting of Cl, Br, and I,

X is, independently, selected from the group consisting of O, S, and NH; and

n is an integer of from 1 to 100, and

wherein, if a functional group comprising an acidic proton is present at position R2, the functional group is protected until after the coupling chemistry is completed, and then subjected to a deprotection step, with the proviso that at least one of R1 and R2 is not H when X is 0.

25. A compound having Formula II:

wherein

X is, independently, selected from the group consisting of O, S, and NH,

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, and disaccharides;

R2 is H, a monosaccharide, a disaccharide, or a polyhydric alcohol;

R3 is a hydrophilic oligomer or polymer selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers; carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides; and

n is an integer of from 1 to 100, with the proviso that at least one of R1 and R2 is not H when X is O.

26. A compound of claim 25 , having the following formula:

wherein:

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides;

R3 is a hydrophilic oligomer or polymer, which can be selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers, carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides;

X is, independently, selected from the group consisting of O, S, and NH; and

n is an integer of from 1 to 100, with the proviso that R1 is not H when X is O.

27. A method of conducting an assay, the method comprising combining with a compound having one of the following general formulas, a blood sample potentially comprising an enzyme capable of cleaving said compound:

wherein

X is, independently, selected from the group consisting of O, S, and NH,

R1 is selected from the group consisting of H, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, and disaccharides;

R2 is H, a monosaccharide, a disaccharide, or a polyhydric alcohol;

R3 is a hydrophilic oligomer or polymer selected from the group consisting of polyalkylene glycols, wherein the polyalkylene glycols can optionally further include NH or S moieties; polycationic polymers; carbohydrates, C1-15 oxyalkyl, —C1-15 aminoalkyl, —C1-15 alkylamino, —(CH2CH2O)n-CH3, —(CH2CH2O)n-SO3H, C1-6-alkyl-C(O)NH2, —(CH2CH2NH)n-H, —SO3H, —C1-6-alkyl-C(O)OH, —SO3Me, C1-6-alkyl-heterocyclyl, monosaccharides, disaccharides; and

n is an integer of from 1 to 100, with the proviso that at least one of R1 and R2 is not H when X is O.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2017
From: WINGER, THEODORE; ECKHARDT, ALLEN E.; GRAHAM, CARRIE; SISTA, RAMAKRISHNA; PAMULA, VAMSEE K.; WANG, TONG; XIONG, YALIN; WU, NING
To: ADVANCED LIQUID LOGIC, INC.
Reel/Frame 040937/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2017
From: SAHA, SANJAY; RAOLJI, GAJENDRASINH BALVANTSINH; DAYAM, RAVEENDRA
To: GVK BIOSCIENCES PRIVATE LIMITED
Reel/Frame 040937/0292 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2017
From: GVK BIOSCIENCES PRIVATE LIMITED
To: ADVANCED LIQUID LOGIC, INC.
Reel/Frame 040937/0383 →
CONFIRMATORY LICENSE Recorded Aug 26, 2015
From: ADVANCED LIQUID LOGIC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036475/0403 →
Continuity (17)
Continuation 14089070 · Nov 25, 2013
Continuation 13738259 · Jan 10, 2013
Continuation 13305820 · Nov 29, 2011
Continuation In Part 12531844
Continuation 13012831 · Jan 25, 2011
Continuation PCTUS2010061118 · Dec 10, 2010
Provisional Application 60896341 · Mar 22, 2007
Provisional Application 61288633 · Dec 21, 2009
Provisional Application 61290296 · Dec 28, 2009
Provisional Application 61325580 · Apr 19, 2010
Provisional Application 61334376 · May 13, 2010
Provisional Application 61359943 · Jun 30, 2010
Provisional Application 61378705 · Aug 31, 2010
Provisional Application 61382564 · Sep 14, 2010
Provisional Application 61392633 · Oct 13, 2010
Provisional Application 61406380 · Oct 25, 2010
Related Publication 20150184219A1 · Jul 2, 2015